Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kitov Pharma Ltd (KTOV)

4.4301   0.17 (3.99%) 09-29 10:35
Open: 4.33 Pre. Close: 4.26
High: 4.48 Low: 4.27
Volume: 265,061 Market Cap: 71M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.598 - 4.62 4.62 - 4.64
Low: 4.08 - 4.103 4.103 - 4.125
Close: 4.22 - 4.26 4.26 - 4.296

Technical analysis

as of: 2020-09-29 10:13:04 AM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 5.43     One year: 6.34
Support: Support1: 4.04    Support2: 3.66
Resistance: Resistance1: 4.65    Resistance2: 5.43
Pivot: 4.22
Moving Average: MA(5): 4.15     MA(20): 4.17
MA(100): 6.12     MA(250): 6.13
MACD: MACD(12,26): -0.33     Signal(9): -0.45
Stochastic oscillator: %K(14,3): 57.45     %D(3): 46.32
RSI: RSI(14): 45.25
52-week: High: 14.40  Low: 2.20  Change(%): -39.6
Average Vol(K): 3-Month: 121254  10-Days: 40658

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
KTOV has closed below upper band by 20.0%. Bollinger Bands are 83.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to KTOV's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 08 Sep 2020
KITOV PHARMA LT/S ADR (KTOV) Stock: What Does the Chart Say? - InvestorsObserver

Tue, 08 Sep 2020
Kitov Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients - GlobeNewswire

Tue, 08 Sep 2020
Form 6-K Kitov Pharma Ltd. For: Sep 08 -

Mon, 07 Sep 2020
Will current price volatility hamper Kitov Pharma Ltd (KTOV) future potential? - Marketing Sentinel

Fri, 04 Sep 2020
Kitov Pharma receives new patents for CM24 and NT219 in China - Seeking Alpha

Thu, 03 Sep 2020
12-month price target for Kitov Pharma Ltd (NASDAQ:KTOV) now sits at $30 - Marketing Sentinel

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17
Shares Float (M) 6
% Held by Insiders 4.67
% Held by Institutions 28.19
Shares Short (K) 643
Shares Short P. Month (K) 1,380

Stock Financials

EPS -7.800
EPS Est This Year -1.040
EPS Est Next Year -0.400
Book Value (p.s.) 9.280
Profit Margin
Operating Margin -753.90
Return on Assets (ttm) -9.1
Return on Equity (ttm) -92.0
Qtrly Rev. Growth
Gross Profit (p.s.) 0.058
Sales Per Share 0.058
EBITDA (p.s.) -0.438
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) 22

Stock Valuations

PE Ratio -0.56
PEG Ratio
Price to Book value 0.47
Price to Sales 75.55
Price to Cash Flow -9.50

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.